Philogen Logo

Philogen

ISIN: IT0005373789 | Ticker: PHIL | LEI: 81560009EA1577917768
Sector: Health CareSub-Industry: Biotechnology
Country: Italy

About Philogen

Company Description

Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the treatment of life-threatening conditions.

Philogen Group mainly discovers and develops targeted anti-cancer drugs, exploiting high-affinity ligands for tumor markers. These ligands – namely human monoclonal antibodies or small molecules – are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The main therapeutic strategy of the Group for the treatment of these diseases is the so-called “tumor targeting”.

Year founded

1996

Headquarters

Piazza La Lizza 7, 53100 Siena – Italy

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

IT0005373789

LEI

81560009EA1577917768

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.